Valuation: DIAGNOS Inc.

Market Cap 52.91M 37.24M 33.27M 31.01M 28.11M 3.54B 53.33M 371M 145M 1.84B 140M 137M 5.9B P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 52.38M 36.87M 32.94M 30.7M 27.84M 3.5B 52.8M 368M 144M 1.82B 138M 135M 5.84B EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
94.56%
Yield 2025 *
-
Yield 2026 -
1 day-8.60%
1 week-9.57%
Current month-11.46%
1 month-5.56%
3 months+60.38%
6 months+66.67%
Current year+13.33%
1 week 0.41
Extreme 0.41
0.49
1 month 0.41
Extreme 0.41
0.53
Current year 0.18
Extreme 0.175
0.53
1 year 0.18
Extreme 0.175
0.53
3 years 0.18
Extreme 0.175
0.57
5 years 0.12
Extreme 0.125
0.59
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 2008-04-30
Chief Operating Officer - 2024-01-15
Director TitleAgeSince
Director/Board Member - 2000-09-20
Director/Board Member 72 2020-09-27
Chairman 69 2025-10-29
Date Insider Type Main position Quantity % Market Cap. Importance
8/28/26 Buy

Director

105,000 0.0872%
8/21/26 Option

Director

-100,000 0.0830%
8/21/26 Option

Director

100,000 0.0830%
Change 5-day change 1-year change 3-year change Capi.($)
-8.60%-9.57%+19.72%-13.27% 40.55M
+1.66%+4.29%-16.75%+66.68% 214B
+1.75%+5.79%-4.32%+16.34% 193B
+0.19%+10.42%-12.32%-29.24% 128B
-0.72%+6.49%+44.68%+127.64% 127B
-0.90%-2.06%+56.23%+468.51% 125B
+6.79%+8.06%-24.54%-36.45% 80.43B
+0.40%+7.78%-18.50%-4.87% 63.43B
+1.85%+4.00%+14.82%+151.66% 46.45B
-3.05%-15.17%-45.06% - 44.27B
Average +0.08%+2.62%+1.40%+83.00% 102.1B
Weighted average by Cap. +0.71%+4.20%+2.21%+94.40%

Financials

2025 2026
Net sales 104K 73.06K 65.27K 60.83K 55.15K 6.94M 105K 729K 285K 3.61M 274K 268K 11.57M 65.48K 46.09K 41.17K 38.38K 34.79K 4.38M 65.99K 460K 180K 2.28M 173K 169K 7.3M
Net income -4.29M -3.02M -2.7M -2.51M -2.28M -286M -4.32M -30.1M -11.78M -149M -11.33M -11.08M -478M -4.56M -3.21M -2.86M -2.67M -2.42M -304M -4.59M -31.98M -12.52M -158M -12.04M -11.78M -508M
Net Debt -164K -115K -103K -95.95K -86.99K -10.94M -165K -1.15M -450K -5.69M -433K -423K -18.25M -525K -370K -330K -308K -279K -35.09M -529K -3.69M -1.44M -18.25M -1.39M -1.36M -58.56M
Projected Income Statement - Annual - DIAGNOS Inc.
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - DIAGNOS Inc.